For R&D use only.

GSK864

  • Catalog NO.:A942469
  • CAS No. : 1816331-66-4
  • Molecular Formula:C30H31FN6O4
  • Molecular Weight: 558.61
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS
COA

Product Details

CAS Number 1816331-66-4 Appearance
Catalog Number A942469 MDL Number
Molecular Formula C30H31FN6O4 Molecular Weight 558.61
Boiling Point Melting Point
Flash Point Density
Synonyms (S)-1-(4-fluorobenzyl)-N3-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3,7-dicarboxamide
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements Class
Precautionary Statements Packing Group

Description

Cabozantinib, also known as XL-184 or BMS-907351, is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several tyrosine receptor kinases. Specifically, cabozantinib appears to have a strong affinity for the hepatocyte growth factor receptor (Met) and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in inhibition of tumor growth and angiogenesis, and tumor regression. Cabozantinib was approved by the U.S. FDA in November 2012 for the treatment of medullary thyroid cancer.

1140909-48-3(malate)

849217-68-1(free base)

Related Products

My Tracks: GSK864
Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

GSK864
(S)-1-(4-fluorobenzyl)-N3-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3,7-dicarboxamide